If there’s one thing that socially responsible businesses have learned, it’s that they can’t go at it alone. Whether it’s implementing responsible sourcing initiatives or creating a positive corporate model to make an impact on sustainability, there is strength in numbers. So where did Ben & Jerry’s turn for help and inspiration for its latest ice cream flavor? Colorado-based New Belgium Brewing. Never has the phrase “polishing off a pint” been so perfectly poised in any partnership for a delicious double-entendre.
Collectively committed to making a better impact in their global communities, the two B Corp companies proudly introduced Salted Caramel Brown-ie Ale ice cream, which will be featured in Ben & Jerry’s Scoop Shops as well as in pints across the country as a Limited Batch flavor this fall (MSRP $4.89). The concoction consists of New Belgium Brown Ale Ice Cream with Salted Caramel Swirls and Fudge Brownies. The ice cream, arriving on shelves this month, was unveiled Wednesday evening at a Washington D.C. launch “Brew-Ha-Ha” in the confines of the historic Howard Theatre. The launch event was heralded as “a night of music, climate activism, beer, and ice cream.” Musicians Galactic and Dr. Dog performed at the unveiling of Ben & Jerry’s newest ice cream flavor to highlight climate activism.
To view the multimedia release go to:
http://www.multivu.com/players/English/7648451-ben-and-jerry-s-new-belgium-brewery/
Chiasma, Inc., a U.S. privately–held biopharma company developing octreotide capsules for the orphan condition acromegaly, today announced two new studies presented at the 97th Endocrine Society (ENDO) Annual Meeting in San Diego, Calif. The studies provide additional data from Chiasma’s Phase III trial and new findings on the patient burden of current injection therapies.
“We now have data to help clinicians determine whether octreotide capsules, if approved, are likely to help their patient with acromegaly maintain response,” said Shlomo Melmed, M.D., senior vice president and dean, Cedars–Sinai Medical Center, Los Angeles and global study principal investigator. “Furthermore, the Phase III results show the safety and efficacy of octreotide capsules can be reliably determined within 12 weeks of initiating therapy.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7436451-endo-chiasma-clinical-data/
Last week, Jennifer Lawrence and other celebrities had indiscrete photos stolen and distributed across the Internet. It’s speculated that their accounts were accessed by a “brute force” attack—which can only be successful if their passwords were weak.
Weak passwords are a risk for businesses, too. Verizon found that 76% of all network intrusions exploit weak or stolen passwords.
To protect critical data, every employee at every business must use strong passwords (which have no fewer than 12 characters). But with an average of 14.3 apps per business, users are likely to take shortcuts by creating passwords that are easy to memorize – and easy to crack.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7286151-intermedia-appid-single-sign-on-passwords-one-click-access/
Subscribe My Channel : https://goo.gl/M4eU1Q
Benefits of Lemon for Reducing Belly Fat Drinking lemon provides a plethora of benefits. This includes losing stomach fat. A recent study shows that people who drink lemon juice before bedtime reduce their body fat mass. It also improves their lipid profile.
To make this bedtime drink taste more effective and better, you can combine lemon with a pitcher of water and other fresh fruits.
Also, a little amount of honey can make a huge difference. Benefits of Cucumber for Reducing Belly Fat For a healthy and flavorful bedtime drink, a bottle of fresh cucumber juice is perfect. If the blend is too strong, add enough amount of water. You can also squeeze some lemons and grate ginger to make this drink tastier.
https://www.youtube.com/watch?v=itoDArHkywA
Witness how drastically our world could change if the earth warms by just one degree.
Six Degrees Could Change the World :
SUN FEBRUARY 10 8P et/pt : http://channel.nationalgeographic.com/channel/sixdegrees/?source=4003
The Ministry of Communications and Mass Media of the Russian Federation has announced that the Federal Law “On the preparation and holding in the Russian Federation the FIFA World Cup 2018™ and the FIFA Confederations Cup 2017 and introduction of the amendments to some Russian Federation legislative acts” was published on the official website of the President of Russia (http://kremlin.ru/acts/news/57003).
The changes to the legislation have concerned the duration of possible entry into the Russian Federation for tourists who plan to cross the Russian federal border using FAN ID. Foreign spectators and stateless persons can enter Russia with their within the time period that starts 10 days prior to the date of the first match and ends on the date of the last match, i.e. it will be possible to enter Russia with a FAN ID from June 4 to July 15, 2018. The FAN ID holders must leave the country no later than July 25, 2018. Foreign spectators and stateless persons can also exit Russia using a FAN ID either in the laminated form or in electronic format if they have valid documents of identification.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8290951-fan-id-2018-fifa-world-cup-exit-russia/
With September marking National Prostate Cancer Awareness Month and the kick-off of the 2015 NFL season, the Urology Care Foundation and the NFL have renewed their commitment to driving prostate health awareness, as well as teamed up to highlight a Public Service Announcement (PSA) focused on educating men about prostate cancer and encouraging them to take charge of their health through the Know Your Stats® campaign.
The Know Your Stats® campaign is a rallying force to connect, educate and inspire men across the country to know their prostate cancer risk and talk to their doctor about whether prostate cancer testing is right for them.
“It is important for men to know their risk and talk to their doctors so they can determine if prostate cancer testing is right for them,” said Richard A. Memo, MD, Chair of the Urology Care Foundation. “Having the tools and facts empowers individuals and their doctors to make informed decisions.”
Prostate cancer is the second most common cancer in America, affecting one in seven men. Odds increase to one in five if they are African American and one in three if they have a family history; however, the educational tools are making an impact. More men are talking with their doctors and getting tested, and fewer men are dying from the disease.
To view the multimedia release go to:
http://www.multivu.com/players/English/7365551-prostate-cancer-know-your-stats-psa/
Spotted: Nick Offerman and his dad Ric fishing in a handmade canoe on a serene and quiet lake, communicating as only fathers and sons do.
Of the experience, Offerman said, “Working with my Dad (aka my hero) was a sincere honor and a treat - especially since all we had to do was go fishing. And if people have enjoyed my stoic expressions, then I expect they’re about to have their hats fly off when they lay eyes on the face of the august edifice from whence I sprung.”
Grab your dad, pour yourselves a glass of Lagavulin and enjoy responsibly.
To view the multimedia release go to:
http://www.multivu.com/players/English/7848951-my-tales-of-whisky-fathers-day/
Fall in love with India and the bustling city of Mumbai in Ajay Kaul’s book of short stories, Mumbai Matinee, truth-based fiction that acts as both memoir and travelogue. Mumbai Matinee portrays the veritable feast of the commerce, people, and danger which make up India’s most populous city and financial capital. Filled with eight interconnected short stories based on Kaul’s life and work there, this charming book is a terrific pleasure read and highly recommended if you plan to visit.
Find out more at https://www.facebook.com/ajaykaulwriter romance, thriller
Ten years after her Blind Date With God began, Joycee is at peace with her past. She has forgiven the unfathomable and wants to share her story. Her book tells the good, bad and ugly truth of the healing process she walked through – bringing with it a strong message that anything is possible to overcome if we are willing to be honest with ourselves. It’s a riveting journey of forgiving herself and those who have harmed her. In the midst of her painful journey is where 414 Ministry was birthed. A nonprofit that empowers and equips victims to become thriving survivors for such a time as this. Find out more and get to know Joycee here- https://www.facebook.com/joyceereynolds/
Email her here – 414ministry@gmail.com
Find out more about 414 Ministry here- http://414ministry.wixsite.com/414ministry Non-Fiction/Christian
Companies in every part of the nation sponsor tax-qualified benefit plans to attract and retain high quality employees. The plans are designed to offer employees tax relief as they build up their retirement through 401k plans or to buy medical and dental type benefits. However, according to EisnerAmper's Pension Services Group, tax relief that benefits both the employer and the plan participants is at risk of being lost if plan sponsors fail to follow basic qualification requirements by maintaining effective internal control structures over their plans.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7461932-eisneramper-employee-benefits/
LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today recognizes that more than one million people in the United States with drug-resistant epilepsy continue to be treated unsuccessfully with drugs, despite the proven effectiveness of non-drug treatment options. LivaNova’s VNS Therapy®, for example, is a medical device treatment specifically designed for people with drug-resistant epilepsy that is already used by more than 85,000 people around the world.
One in three people with epilepsy has the type that is not well controlled with drugs, called drug-resistant epilepsy. For those people, prescribing more medicine is usually not the most effective option. In fact, research shows that if you haven’t found seizure freedom after your first two drugs, there is a 95 percent chance that no drug or combination of drugs will result in seizure freedom.
“Despite what we know about drug-resistant epilepsy, the majority of people affected by this condition will continue to be prescribed additional medications instead of being evaluated for surgery or seen in a specialized epilepsy facility,” said Jason Richey, president of LivaNova’s U.S. Region and general manager of the Neuromodulation Business Franchise. “This treatment gap means over one million individuals in the U.S. with undertreated epilepsy remain at risk for dangerous side effects of continued seizures, including injury, depression, memory issues and death.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7966451-livanova-vns-therapy-epilepsy/
